Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001245249 | SCV001418523 | uncertain significance | Peroxisome biogenesis disorder | 2022-08-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 522 of the PEX6 protein (p.Arg522Gln). This variant is present in population databases (rs374396138, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with PEX6-related conditions. ClinVar contains an entry for this variant (Variation ID: 969820). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV002246231 | SCV002517355 | likely pathogenic | Peroxisome biogenesis disorder 4A (Zellweger) | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829952 | SCV002077308 | uncertain significance | Zellweger spectrum disorders | 2020-03-13 | no assertion criteria provided | clinical testing |